Randomized Clinical Trial for Primary Molar Pulpotomy, Biodentine Vs Formocresol-ZOE
Not Applicable
Completed
- Conditions
- Deep Dental Caries
- Registration Number
- NCT02201498
- Lead Sponsor
- Université de Montréal
- Brief Summary
This is a RCT that will compare the clinical and radiographic success of pulpotomies on primary molars between the traditional technique (Formocresol/ZOE) and the new technique with Biodentine. 180 pulpotomies (90 in each group) will be followed for a period of 12 months.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
- ASA I and II
- less than 1/3 of physiologic root resorption
- asymptomatic tooth (with no history of symptoms)
- no clinical or radiological sign of pathology
- vital tooth, with carious pulpal exposure
- hemostasis must be obtained simply with pressure in less than 5 min
- teeth restored with stainless steel crowns
Exclusion Criteria
- more than 10 y.o.
- symptomatic tooth (presently or history of symptoms)
- previous pulpal treatment on the tooth
- necrotic pulp
- hyperemic pulp
- inadequate operative technique, defective restauration
- non diagnostic x-ray (pre or post treatment)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method clinical success 12 months post treatment radiographic success 12 months post treatment
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which Biodentine promotes pulp healing in primary molars with deep caries?
How does the clinical success rate of Biodentine pulpotomies compare to formocresol-ZOE in pediatric dentistry?
Are there specific biomarkers that predict long-term radiographic success in primary molar pulpotomies using Biodentine?
What adverse events are associated with formocresol-ZOE versus Biodentine in primary tooth treatments?
What alternative materials or combination therapies are being explored for primary molar pulpotomies alongside Biodentine?
Trial Locations
- Locations (1)
CHU Sainte-Justine
🇨🇦Montreal, Quebec, Canada
CHU Sainte-Justine🇨🇦Montreal, Quebec, Canada